Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
08/2002
08/20/2002CA2219648C Derivatives of 6,8-difluoro-7-hydroxycoumarin
08/20/2002CA2045077C Anti-epileptics
08/15/2002WO2002063030A2 Charge tags and separation of nucleic acid molecules
08/15/2002WO2002062809A1 Ruthenium complex and process for producing alcohol compound
08/15/2002WO2002062808A1 Process for purification of phosphate esters
08/15/2002WO2002062398A2 Radioactively labelled conjugates of phosphonates
08/15/2002WO2002062157A2 Methods for treating phosphatide-containing mixtures
08/15/2002WO2002062156A2 Methods for treating organic acid-treated phosphatides
08/15/2002WO2002034757A3 Production of metal chalcogenide nanoparticles
08/15/2002WO2002034756A3 Beta-substituted beta-aminoethyl phosphonates
08/15/2002WO2002030860A3 Ketone compounds and compositions for cholesterol management and related uses
08/15/2002WO2002016381B1 Composition and method for inhibiting platelet aggregation
08/15/2002WO2002010114A3 Transesterified fatty esters for lubricant and refrigerant oil system
08/15/2002US20020111517 Hydroformylation catalyst comprising a complex with ligands having a structure derived from bisphenol A
08/15/2002US20020111515 Process for the preparation of non-chiral and optically active organic compounds containing hydroxyl groups
08/15/2002US20020111488 Beta-substitued beta-aminoethyl phosphonate derivatives
08/15/2002US20020111487 Used for hydroformylation catalysts of linear olefins having terminal and internal double bonds
08/15/2002US20020111438 Dendritic macromolecules for metal-ligand catalyzed processes
08/15/2002US20020111378 Inhibitors of IMPDH enzyme
08/15/2002US20020111332 Alpha-substituted beta-aminoethyl phosphonate derivatives
08/15/2002CA2436746A1 Charge tags and the separation of nucleic acid molecules
08/15/2002CA2434302A1 Therapeutic and diagnostic compounds, compositions, and methods
08/14/2002EP1231227A1 Poly(phosphonoarylacetylene) and chiral sensor comprising the same
08/14/2002EP1231213A1 Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields
08/14/2002EP1230549A2 Method for solubilising optical markers
08/14/2002EP1230249A1 Transition metal complexes with bidentate ligand having an imidazole ring
08/14/2002EP1230248A2 Transition metal complexes attached to a polymer via a flexible chain
08/14/2002EP1230243A1 Poycyloalkylpurines as adenosine receptor antagonists
08/14/2002EP1230207A2 Metathesis syntheses of pheromones or their components
08/14/2002EP1230200A2 C 13? alcohol mixture and functionalised c 13? alcohol mixture
08/14/2002EP1066298B1 Preparation of phosphine ligands
08/14/2002EP0991615B1 Pro-fragrance linear acetals and ketals
08/14/2002EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors
08/14/2002EP0722439B1 Hiv protease inhibitors
08/14/2002EP0708761B1 Enhanced relaxivity monomeric and multimeric compounds
08/14/2002EP0703916B1 14-substituted marcfortines and derivatives useful as antiparasitic agents
08/14/2002DE10107045A1 Verfahren zur Polymerisation von Olefinen A process for the polymerization of olefins
08/14/2002DE10107043A1 Verfahren zur Polymerisation von Olefinen A process for the polymerization of olefins
08/14/2002DE10106348A1 Als Katalysator oder zur Herstellung eines Katalysatorsystems geeignete Verbindung As a catalyst or for the preparation of a catalyst system suitable compound
08/14/2002CN1364156A Novel naphthalene ureas as glucose uptake enhancers
08/14/2002CN1363556A Process for preparing (cycloheptylamino) methylene biphosphonic acid
08/14/2002CN1363553A Process for preparing VA derivative
08/14/2002CN1089086C Luminide and macroluminide class of pharmaceuticals
08/13/2002US6433226 Reacting an alcohol with a triarylphosphine compound
08/13/2002US6433183 (R)-3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-3-methyl-1,6-dihydroimidazo[1,2-a]imidazole-2,5-dione
08/13/2002US6433163 Extraction, separation
08/13/2002US6433112 π-complex compounds
08/13/2002US6432941 Vanadium compounds for treating cancer
08/13/2002US6432933 Malaria therapy; alzheimer's disorders
08/08/2002WO2002060879A2 Bacterial gyrase inhibitors and uses thereof
08/08/2002WO2002024650A3 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
08/08/2002WO2002008211A3 Benzothiazepines and their use as antihyperlipidemics
08/08/2002US20020107413 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides
08/08/2002US20020107345 Complex of a selected transition metal with a monoanionic ligand that has at least three atoms that may coordinate to the transition metal, one of which is an oxygen at and one of which is a nitrogen in an imine radical
08/08/2002US20020107290 Inhibiting activated blood-coagulation factor X
08/08/2002US20020107159 Phosphate fluorosurfactants for use in carbon dioxide
08/08/2002US20020104169 Durable fabric enhancement
08/08/2002DE10105104A1 Verfahren zur Herstellung von nicht-chiralen und optisch aktiven Hydroxygruppen enthaltenden organischen Verbindungen Process for the preparation containing non-chiral and optically active hydroxy organic compounds
08/07/2002EP1229037A1 Heterocyclic N-acetonylbenzamides and their use as fungicides
08/07/2002EP1229028A1 Heterocyclic N-acetonylbenzamides and their use as fungicides
08/07/2002EP1229027A1 Heterocyclic N-acetonylbenzamides and their use as fungicides
08/07/2002EP1229019A1 Process for the production of optically active cyclic enaminone derivatives
08/07/2002EP1228762A2 Method for preparation of disodium pamidronate
08/07/2002EP1228236A2 Compositions for transfecting nucleic acids and their use
08/07/2002EP1228137A1 Flame-resistant polycarbonate moulding materials
08/07/2002EP1228136A1 Flame-resistant polycarbonate abs blends
08/07/2002EP1228080A2 Compositions and methods for double-targeting virus infections and targeting cancer cells
08/07/2002EP1228076A1 A substantially cell membrane impermeable compound and use thereof
08/07/2002EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
08/07/2002EP1228034A2 Chiral phosphines, transition metal complexes thereof and uses thereof in asymmetric reactions
08/07/2002EP1135399B1 Process for preparing acylphosphines and derivatives
08/07/2002CN1362962A Method of producing glyphosate or a salt thereof
08/07/2002CN1362935A Method for preparing silica (SiO2) from rice bran
08/07/2002CN1362415A Prepn of high-purity acephate powder (2)
08/07/2002CN1362414A Prepn of high-purity acephate powder (1)
08/07/2002CN1362413A Polymelaminyl metaphosphate as flame retardant and its prepn
08/07/2002CN1088712C Phosphonate nucleotide compounds
08/07/2002CN1088696C Improved metal-ligand complex catalyzed processes
08/06/2002US6429329 Phosphonation of aldehyde or ketone with hydrocarbyl phosphite in presence of basic catalyst to form 1-hydroxy hydrocarbylphosphonate; esterification with acetic anhydride using acid catalyst; carboxylic acid removal
08/06/2002US6429203 Farnesyl-protein transferase inhibitors
08/06/2002US6428999 Useful in medicine, carbohydrate engineering, cell engineering
08/06/2002CA2055219C 2-substituted bisindenylmetallocenes, process for their preparation, and their use as catalysts in the polymerization of olefins
08/01/2002WO2002059243A2 Zwitterionic gemini surfactants for use in carbon dioxide
08/01/2002WO2002059165A2 Polymerization of olefinic compounds
08/01/2002WO2002059133A1 Bridged biphospholes and metallocenes prepared therefrom
08/01/2002WO2002058698A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/01/2002WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
08/01/2002WO2001068655A3 Caprolactam derivatives and uses thereof
08/01/2002US20020103393 Purifying process for phosphatidylserine
08/01/2002US20020103375 Novel phosphinine compounds and metal complexes thereof
08/01/2002US20020103166 2-(4-Chlorophenoxy)-2-oxo-1,3,2-oxazaphosphorinane-3-aceto -hydroxamic acid, for example; antiathritic, -tumor, -metastasis, -proliferative and -ulcer agents; multiple sclerosis; vision defects; skin disorders
08/01/2002US20020103161 Novel heterocycles
08/01/2002US20020102624 Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes
08/01/2002US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization
08/01/2002CA2735478A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/01/2002CA2735267A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
07/2002
07/31/2002EP1227101A1 Process for the preparation of condensed phosphoric acid esters
07/31/2002EP1227085A1 Process for producing optically active naphthalene derivative and optical resolver therefor
07/31/2002EP1226147A1 Phosphites
07/31/2002EP1226117A1 A process for producing bismuth dithiocarbamates and dithiophosphorates